These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9310494)

  • 1. Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression.
    Morente MM; Piris MA; Abraira V; Acevedo A; Aguilera B; Bellas C; Fraga M; Garcia-Del-Moral R; Gomez-Marcos F; Menarguez J; Oliva H; Sanchez-Beato M; Montalban C
    Blood; 1997 Sep; 90(6):2429-36. PubMed ID: 9310494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus-latent membrane protein 1 expression has a favorable influence in the outcome of patients with Hodgkin's Disease treated with chemotherapy.
    Montalban C; Abraira V; Morente M; Acevedo A; Aguilera B; Bellas C; Fraga M; Del Moral RG; Menarguez J; Oliva H; Sanchez-Beato M; Piris MA
    Leuk Lymphoma; 2000 Nov; 39(5-6):563-72. PubMed ID: 11342339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.
    Kanavaros P; Stefanaki K; Vlachonikolis J; Eliopoulos G; Kakolyris S; Rontogianni D; Gorgoulis V; Georgoulias V
    Histol Histopathol; 2000 Apr; 15(2):445-53. PubMed ID: 10809363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous apoptosis of Reed-Sternberg and Hodgkin cells; clinical and pathological implications in patients with Hodgkin's disease.
    Smolewski P; Niewiadomska H; Los E; Robak T
    Int J Oncol; 2000 Sep; 17(3):603-9. PubMed ID: 10938405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic relevance of apoptosis-related proteins in classical Hodgkin's lymphomas.
    Vassallo J; Metze K; Traina F; de Souza CA; Lorand-Metze I
    Leuk Lymphoma; 2003 Mar; 44(3):483-8. PubMed ID: 12688319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
    Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
    Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the prognostic impact of the Epstein-Barr virus-encoded latent membrane protein-1 expression in Hodgkin's disease.
    Glavina-Durdov M; Jakic-Razumovic J; Capkun V; Murray P
    Br J Cancer; 2001 May; 84(9):1227-34. PubMed ID: 11336475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of retinoblastoma protein and P16 proteins in classic Hodgkin lymphoma: relationship with expression of p53 and presence of Epstein-Barr virus in the regulation of cell growth and death.
    Kim LH; Peh SC; Poppema S
    Hum Pathol; 2006 Jan; 37(1):92-100. PubMed ID: 16360421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low apoptotic index & bak expression in EBV-associated childhood classical Hodgkin lymphoma.
    Dinand V; Malik A; Mohanty B; Chander B; Arya LS; Dawar R
    Indian J Med Res; 2009 Nov; 130(5):526-32. PubMed ID: 20090100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene expression in tumour cells of pediatric Hodgkin's disease in Argentina--correlation with Epstein Barr virus presence.
    Preciado MV; Cristobal E; Menarguez J; Martinez Montero JC; Diez B; De Matteo E; Grinstein S
    Pathol Res Pract; 1998; 194(1):25-31. PubMed ID: 9542744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relapsed Hodgkin's lymphoma: immunostaining patterns in relation to survival.
    Amini RM; Enblad G; Engström P; Christensson B; Glimelius B; Sundström C
    Leuk Lymphoma; 2002 Jun; 43(6):1253-60. PubMed ID: 12152993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anomalous retinoblastoma protein expression in Sternberg-Reed cells in Hodgkin's disease: a comparative study with p53 and Ki67 expression.
    Sánchez-Beato M; Martínez-Montero JC; Doussis-Anagnostopoulou TA; Gatter KC; García J; García JF; LLoret E; Piris MA
    Br J Cancer; 1996 Oct; 74(7):1056-62. PubMed ID: 8855974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunohistochemical prognostic factors of primary refractory Hodgkin's lymphoma].
    Filatova LV; Gershanovich ML; Plotnikova AA; Turkevich EA; Ivantsov AO; Klimashevskiĭ VF
    Vopr Onkol; 2014; 60(5):625-9. PubMed ID: 25816669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of EBV, proliferation rate, and Bcl-2 expression in Hodgkin's disease in childhood.
    Claviez A; Tiemann M; Peters J; Kreipe H; Schneppenheim R; Parwaresch R
    Ann Hematol; 1994 Feb; 68(2):61-6. PubMed ID: 8148417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expression of Ki-67 and Bcl-2 in Hodgkin's lymphoma: correlation with the International Prognostic Score and bulky disease: a study by the Serbian Lymphoma Study Group (SLG).
    Jakovic LR; Mihaljevic BS; Jovanovic MD; Bogdanovic AD; Martinovic VM; Kravic TK; Bumbasirevic VZ;
    Med Oncol; 2007; 24(1):45-53. PubMed ID: 17673811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of proliferating cell nuclear antigen (PCNA) and p53, bcl-2 or C-erb B-2 proteins on Reed-Sternberg cells: prognostic significance in Hodgkin's disease.
    Smolewski P; Niewiadomska H; Błonski JZ; Robak T; Krykowski E
    Neoplasma; 1998; 45(3):140-7. PubMed ID: 9717525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Epstein-Barr virus latent gene products and related cellular activation and adhesion molecules in Hodgkin's disease and non-Hodgkin's lymphomas arising in patients without overt pre-existing immunodeficiency.
    Kanavaros P; Jiwa M; van der Valk P; Walboomers J; Horstman A; Meijer CJ
    Hum Pathol; 1993 Jul; 24(7):725-9. PubMed ID: 8100553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epstein-Barr viral infection in extranodal lymphoma of the head and neck: correlation with prognosis and response to treatment.
    Bahnassy AA; Zekri AR; Asaad N; El-Houssini S; Khalid HM; Sedky LM; Mokhtar NM
    Histopathology; 2006 Apr; 48(5):516-28. PubMed ID: 16623777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to Epstein-Barr virus-encoded latent membrane protein-1 (LMP1) and expression of LMP1 in juvenile Hodgkin's disease.
    Meij P; Vervoort MB; Bloemena E; Schouten TE; Schwartz C; Grufferman S; Ambinder RF; Middeldorp JM
    J Med Virol; 2002 Nov; 68(3):370-7. PubMed ID: 12226824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic factors in Hodgkin's disease: multivariate analysis of 327 patients from a single institution.
    Smolewski P; Robak T; Krykowski E; Blasiñska-Morawiec M; Niewiadomska H; Pluzanska A; Chmielowska E; Zambrano O
    Clin Cancer Res; 2000 Mar; 6(3):1150-60. PubMed ID: 10741746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.